Rezultati pretraživanja
  1. New article: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.

  2. New article: Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

  3. prije 3 sata

    Veneto and ibrutinib in

  4. prije 3 sata
  5. prije 5 sati

    Cello Health and Acess Intelligence settle terms of Pulsar deal via

  6. prije 6 sati

    (: ) Cello Health PLC: Settlement with Access Intelligence []

  7. New article: Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.

  8. New article: Serum levels of hsa-miR-16-5p, -29a-3p, -150-5p, -155-5p and -223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.

  9. New article: Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

  10. New article: The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma.

  11. New article: Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation.

  12. 4. velj

    Congratulations to Stuart Blakemore for his paper in on clinical significance of TP53, BIRC3, ATM and MAPK-ERK in

  13. 4. velj

    CLL Support is dedicated to providing education, support, and advocacy to help empower people living with CLL.

  14. 3. velj

    Thank you to for helping us to further explore effective communication & language in the EYFS. It was great to explore with you opportunities for effectively developing effective language in the EYFS enabling environment too

  15. 3. velj

    Novel Agents, Approaches Advancing Paradigm

  16. 3. velj
  17. 3. velj

    A key educational event for all clinical scientists and clinicians interested in .

  18. 2. velj

    That’s a lot of mutual weekends; must be up to 10 trials by now!

  19. 1. velj

    Study Shows Single-Cell Analysis Can Gauge Patients’ Response Rates:

  20. 31. sij
    Odgovor korisniku/ci

    Good news for patients but the question is how long before Irish patient have access?

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.